Clara Shen

Clara Shen is a highly educated professional with a diverse background in biochemistry, business administration, and healthcare policy.

She holds a Bachelor of Arts (BA) in Biochemistry from Harvard University, an MBA in Business Administration and Management from INSEAD, and an MBA from China Europe International Business School (CEIBS).

Clara has a strong academic foundation, having studied at prestigious institutions like Thomas Jefferson High School for Science and Technology, Wei Hua Chinese School, and Harvard Business School.

Her career has seen her in various roles, including Executive at Dandelion Chocolate, Investments at C1, and Mars Wrigley Business Development & Ventures at Mars.

She also served as the Catalyst and Head of Emerging Markets, as well as Co-head of the Mutuality Lab at Mars.

Clara held positions in Corporate Affairs and Issues Management, and she was involved in the founding of SteMing Asia, which later became part of MedCell Biosciences.

Her experience includes working as a Business Analyst in Consulting & Services at IMS Health, as well as contributing to Healthcare Policy at the Office of Senator Joseph I. Lieberman.

Clara also has a background in Biomedical Research across various companies, showcasing her expertise in multiple areas within the healthcare and business sectors.

Inspired by the quote 'Fight for the things that you care about, but do it in a way that will lead others to join you' by RBG, Clara has demonstrated a commitment to making a positive impact through her work and leadership.